EDBI backs $500m Series G investment in biotech firm Moderna Therapeutics

EDBI backs $500m Series G investment in biotech firm Moderna Therapeutics

Moderna Therapeutics, a clinical-stage biotechnology firm that develops messenger RNA (mRNA) therapeutics and vaccines, has secured $500 million in a round participated by Singapore-based EDBI and Sequoia Capital China, it announced in a release.

New investors include a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius BaerEDBI and Sequoia Capital China. Existing investors that also participated in this round include Pictet, Fidelity Management & Research Company, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter